ArticleActas espanolas de psiquiatria2025
Factors Contributing to Sexual Dysfunction in Female Schizophrenia Patients During Recovery: A Multifactorial Analysis.
Article in Actas espanolas de psiquiatria, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFemale patients with schizophrenia may experience sexual dysfunction during the recovery period. Therefore, this study conducted a multifactorial analysis to identify factors impacting sexual dysfunction, aiming to aid in developing effective personalized intervention strategies and improving sexual function recovery in these patients.
methodsThis retrospective study included the clinical data from 261 female schizophrenia patients treated at the First Affiliated Hospital of Jinzhou Medical University, diagnosed between February 2022 and March 2024. Based on the total Female Sexual Function Index (FSFI) scores, the patients were divided into the female sexual dysfunction (FSD) group (n = 69) and the non-female sexual dysfunction (non-FSD) group (n = 192). The clinical data of these patients were evaluated using the FSFI, Hamilton Depression Rating Scale (HAMD), Hamilton Anxiety Rating Scale (HAMA), and Olson Marital Quality Questionnaire. Furthermore, univariate and multivariate logistic regression analyses were used to investigate the factors influencing sexual dysfunction in these patients.
resultsThe FSD group exhibited significantly lower scores in sexual desire, orgasm, and sexual satisfaction than those in the non-FSD group (p < 0.001). Analysis revealed that menstrual status, reproductive history, and mental health status (anxiety and depression) were significantly associated with sexual dysfunction (p < 0.05). Furthermore, marital satisfaction, personality compatibility, spousal communication, conflict resolution methods, and sexual life were significantly linked to sexual dysfunction (p < 0.05). Additionally, childbirth (Odds Ratio (OR) = 2.531, 95% Confidence Interval (CI) = 1.025-6.25, p = 0.044), marital satisfaction (OR = 0.886, 95% CI = 0.824-0.952, p = 0.001), conflict resolution methods (OR = 0.816, 95% CI = 0.743-0.897, p < 0.001), sexual life (OR = 0.929, 95% CI = 0.876-0.986, p = 0.016), anxiety (OR = 1.459, 95% CI = 1.231-1.729, p < 0.001), and depression (OR = 1.116, 95% CI = 1.008-1.236, p = 0.035) were found as independent influencing factors for sexual dysfunction in these patients during the recovery phase.
conclusionChildbirth, anxiety, depression, marital satisfaction, conflict resolution methods, and sexual life serve as independent influencing factors for sexual dysfunction in female schizophrenia patients during the recovery phase. Management approaches targeting these factors can significantly improve sexual dysfunction in this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.